Vasculitis & polymyalgia rheumatica

Serum immunoreactivity to neurofilament-medium shows high sensitivity and specificity in patients with Behçet disease

RMD OpenPublished Diagnostic accuracy study

Authors' conclusion

These findings reveal the ubiquitous presence of NF-M immunoreactivity, reportedly cross-reacting with bacterial heat shock protein 65, in BD sera.

Study context

Population
Patients with behçet disease (BD), systemic lupus erythematosus (SLE), multiple sclerosis (MS), psoriatic arthritis (PsA) and non-Behçet uveitis, and healthy donors76 patients · 22 healthy donors
Participants
98 patients
Comparison
Serum NF-M immunoreactivity in BD vs SLE, MS, PsA, non-Behçet uveitis and healthy donors
  • BDn = 33
  • MSn = 16
  • SLEn = 15
  • PsAn = 9
  • Non-Behçet uveitis (NBU)n = 3
  • Healthy donorsn = 22reference
Outcome
Sensitivity and specificity of serum NF-M immunoreactivity
Methodological detailsindependent replication cohort, immunolabelling of mouse brain tissue sections with confocal microscopy
  • Independent replication cohort
  • Immunolabelling of mouse brain tissue sections with confocal microscopy

Performance

As reported in the abstract

Fine filamentous staining pattern consistent with NF-M immunolabelling in axons

BD

97%

32 of 33

Further findings

Other staining patterns

MS sera: thick filamentous staining attributed to oligodendrocytes and myelin-forming processes
SLE sera: intense labelling of all cell nuclei, consistent with immunoreactivity against nuclear antigens

Original publication

Serum immunoreactivity to neurofilament-medium shows high sensitivity and specificity in patients with Behçet disease. RMD Open. Published 30 May 2025. doi:10.1136/rmdopen-2024-005100

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.